12.63USD-3.99%Mkt Cap: 365.81M USDP/E: —Last update: 2026-06-01
Enanta Pharmaceuticals, Inc., a biotechnology company, discovers and develops small molecule drugs for virology and immunology indications. The company's product pipeline comprises EDP-514, which is in phase 1b clinical …
Industry Peers
Biotechnology111.39BUSDP/E 26.0
100.62BDKKP/E 19.4
62.97BUSDP/E 14.7
48.39BEURP/E 31.7
44.65BEURP/E 37.2
40.10BUSDP/E 75.3
35.22BUSD—
32.91BSEKP/E 48.6
Indicators:|
Key Statistics
Company
Market Cap365.81M USD
Enterprise Value405.51M USD
Revenue (TTM)69.21M USD
Gross Profit69.21M USD
Net Income (TTM)-81.89M USD
Revenue/Share2.754 USD
Last Price12.63 USD
Fiscal Year EndSep 2025
MR QuarterMar 2026
Employees120
CountryUS
SectorHealthcare
IndustryBiotechnology
ISINUS29251M1062
Valuation
P/E (Trailing)—
P/E (Forward)-6.73
PEG—
EV/EBITDA-7.31
EV/Revenue5.86
P/S5.53
P/B3.28
EPS (TTM)-2.60
EPS (Forward)-1.96
52W Range
5.88060% of range17.15
52W High17.15 USD
52W Low5.880 USD
Profitability
Gross Margin100.00%
Oper. Margin-69.07%
EBITDA Margin-80.12%
Profit Margin-125.36%
ROE-126.53%
ROA-29.17%
Growth
Revenue Growth15.00%
Earnings Growth—
Cash Flow & Leverage
Operating CF-19.27M USD
CapEx (TTM)12.90M USD
FCF Margin11.11%
FCF Yield2.10%
Net Debt22.84M USD
Net Debt/EBITDA-0.41
Balance Sheet
Debt/Equity0.89
Current Ratio3.84
Quick Ratio3.69
Book Value/Sh4.012 USD
Cash/Share5.632 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 USD
Div. Yield—
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Analyst Consensus
Rating1.2 (Strong Buy)
Target (Mean)20.14 USD
Target Range14.00 USD – 28.00 USD
# Analysts7
Ownership
Shares Out.29.08M
Float20.06M
Insiders4.68%
Institutions92.82%
Short Interest
Short Ratio12.6d
Short % Float9.07%
Short % Out.7.58%
Shares Short2.20M
Short (prev mo.)2.10M
Technical
SMA 5013.64 (-7.4%)
SMA 20012.43 (+1.6%)
Beta1.01
S&P 52W Chg27.94%
Avg Vol (30d)177.57K
Avg Vol (10d)219.02K
Technical Indicators
RSI (14)41.1
MACD-0.1639
MACD Signal-0.0321
MACD Hist.-0.1317
BB Upper15.58 USD
BB Middle14.11 USD
BB Lower12.64 USD
BB Width20.83%
ATR (14)0.6919 USD
Vol Ratio (20d)0.32x